Brief: Ironwood Pharmaceuticals Q1 Revenue USD 74.877 Million Vs. IBES Estimate USD 105.8 Million
09/05/2024 12:00
May 09 (Reuters) - Ironwood Pharmaceuticals Q1 EPS USD -0.03. * Q1 adjusted net income USD -2.933 million vs. IBES estimate USD 19.9 million * Q1 basic EPS USD -0.03 * Q1 net income USD -4.162 million * Q1 adjusted EBITDA USD 12.757 million * Q1 operating expenses USD 63.857 million
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation